Nanoformulations further amplify these effects: for instance, quercetin-loaded polymeric nanoparticles achieve sustained Akt inhibition in breast cancer cells, reducing phosphorylated Akt levels significantly more than free quercetin [119]. The gene discussed is AKT1; the disease is breast carcinoma.